Patients with tuberculous uveitis may present with a variety of symptoms, including redness of the eye, blurred vision, eye pain, and sensitivity to light (photophobia). Some may experience floaters, which are small shapes that appear to float in the field of vision. The condition can affect one or both eyes and may be associated with systemic symptoms of TB, such as persistent cough, fever, night sweats, and weight loss.

Diagnosing tuberculous uveitis involves a thorough clinical evaluation and a series of tests. An ophthalmologist will perform a detailed eye examination, including slit-lamp biomicroscopy to assess the anterior and posterior segments of the eye. Additional tests may include:

• Tuberculin Skin Test (TST) or Interferon-Gamma Release Assays (IGRAs): To detect TB infection.
• Chest X-ray: To identify any pulmonary involvement.
• Polymerase Chain Reaction (PCR): To detect Mycobacterium tuberculosis DNA in ocular fluids.
• Blood Tests: To assess overall health and rule out other causes of uveitis.

The primary treatment for tuberculous uveitis is anti-tubercular therapy (ATT), which typically includes a combination of antibiotics such as isoniazid, rifampicin, ethambutol, and pyrazinamide. The treatment duration is usually six to nine months, depending on the severity and response. Corticosteroids may be prescribed to reduce inflammation and prevent complications. Regular follow-up with an ophthalmologist is crucial to monitor the response to treatment and adjust medications as needed.

With timely and appropriate treatment, the prognosis for tuberculous uveitis is generally favorable. Most patients experience significant improvement in symptoms and preservation of vision. However, delayed diagnosis or inadequate treatment can lead to complications such as cataracts, glaucoma, or permanent vision loss. Regular monitoring and adherence to the treatment regimen are essential for a positive outcome.

Tuberculous uveitis is caused by the bacterium Mycobacterium tuberculosis. It can occur as a result of direct infection of the eye or as an immune-mediated response to systemic TB infection. The exact mechanism is not fully understood, but it is believed that the bacteria can spread to the eye through the bloodstream or lymphatic system.

Tuberculous uveitis is more common in regions with high prevalence of tuberculosis, such as parts of Africa, Asia, and Eastern Europe. It is relatively rare in countries with low TB incidence. Individuals with compromised immune systems, such as those with HIV/AIDS, are at higher risk of developing this condition.

The pathophysiology of tuberculous uveitis involves the infiltration of the uveal tissue by immune cells in response to Mycobacterium tuberculosis. This immune response leads to inflammation and the characteristic symptoms of uveitis. The inflammation can affect various parts of the uvea, including the iris, ciliary body, and choroid, leading to different forms of uveitis.

Preventing tuberculous uveitis primarily involves controlling and preventing tuberculosis infection. This includes vaccination with the Bacillus Calmette-Guérin (BCG) vaccine in countries where TB is common, early detection and treatment of active TB cases, and public health measures to reduce transmission. For individuals with known TB exposure, regular screening and prophylactic treatment may be recommended.

Tuberculous uveitis is a rare but serious eye condition caused by Mycobacterium tuberculosis. It presents with symptoms of eye inflammation and can lead to vision problems if not treated promptly. Diagnosis involves a combination of eye examinations and tests for TB infection. Treatment includes anti-tubercular therapy and corticosteroids to manage inflammation. With appropriate care, the prognosis is generally good, but early detection and adherence to treatment are crucial.

If you have been diagnosed with tuberculous uveitis, it is important to follow your doctor's treatment plan closely. This will likely include a combination of antibiotics to treat the underlying TB infection and medications to reduce eye inflammation. Regular check-ups with your eye specialist are essential to monitor your progress and adjust treatment as needed. Be sure to report any changes in your symptoms promptly. Understanding your condition and staying informed about your treatment can help you manage your health effectively.